Market Research Logo

France Pharmaceuticals and Healthcare Report Q2 2016

France Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Improving consumer and business indices for the French economy will continue to pose upsiderisks to the pharmaceuticals and healthcare sector's ongoing recovery in terms of growth rates. However,supply side factors will continue to weigh negatively on fixed investment rates in the pharmaceuticalindustry, as labour market structural deficiencies are not expected to recede in the foreseeable future. Morebroadly, as pharmaceutical firms seek to increase productivity in a short time frame whilst capping costs,we will likely continue to observe some degree of innovation in business models, such as the openinnovation agreement signed in H215 between Sanofi and AstraZeneca This will eventually allow for fasterinnovation rates through the direct exchange of 210,000 compounds from the companies' respectiveproprietary compound libraries.

Headline Expenditure Projections

Pharmaceuticals: EUR33.46bn (USD36.80bn) in 2015 to EUR33.37bn (USD35.71bn) in 2016; -0.3% inlocal currency terms and -3.0% in US dollar terms. Forecast broadly in line with last quarter.

Healthcare: EUR253.47bn (USD278.82bn) in 2015 to EUR261.32bn (USD279.61bn) in 2016; +3.1% inlocal currency terms and 0.3% in US dollar terms. Forecast revised slightly upwards from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (France 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (France 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (France 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (France 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (France 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (France 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (France 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (France 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (France 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (France 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (France 2014-2020)
Industry Risk/Reward Index
Western Europe Risk/Reward Index
France Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing & Reimbursement Regime
Table: France Reimbursement Categories
Market Overview
Healthcare Sector
Table: Projected Regional Ranking Of Physicians, 2017
Table: Healthcare Personnel (France 2010-2015)
Table: Healthcare Activity (France 2010-2015)
Table: Healthcare Resources (France 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
GlaxoSmithKline
Ipsen
Merck & Co
Novartis
Sanofi
Servier
Demographic Forecast
Table: Population Headline Indicators (France 1990-2025)
Table: Key Population Ratios (France 1990-2025)
Table: Urban/Rural Population & Life Expectancy (France 1990-2025)
Table: Population By Age Group (France 1990-2025)
Table: Population By Age Group % (France 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report